• LAST PRICE
    11.6700
  • TODAY'S CHANGE (%)
    Trending Up0.4200 (3.7333%)
  • Bid / Lots
    10.5000/ 1
  • Ask / Lots
    11.9900/ 9
  • Open / Previous Close
    11.3000 / 11.2500
  • Day Range
    Low 11.3000
    High 11.9900
  • 52 Week Range
    Low 7.2100
    High 16.8800
  • Volume
    234,800
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 11.25
TimeVolumeKALV
09:32 ET194911.3
09:34 ET10011.31
09:36 ET10011.4086
09:38 ET30111.47
09:39 ET30011.46
09:41 ET20011.505
09:43 ET220011.62
09:45 ET40011.6
09:48 ET152011.63
09:50 ET50011.66
09:52 ET20311.67
09:54 ET40011.72
09:56 ET40011.72
09:57 ET273411.76
09:59 ET24011.83
10:01 ET50011.82
10:03 ET30011.82
10:08 ET90011.81
10:10 ET10011.81
10:12 ET170011.77
10:14 ET150011.82
10:15 ET10011.82
10:17 ET142811.82
10:19 ET40011.92
10:21 ET10011.99
10:24 ET120011.945
10:26 ET191011.927
10:28 ET20011.9
10:30 ET50011.88
10:32 ET50011.8
10:35 ET170011.8
10:37 ET20011.805
10:39 ET243611.85
10:42 ET50011.86
10:44 ET10011.86
10:46 ET20011.88
10:48 ET160011.8
10:50 ET20011.83
10:53 ET104311.83
10:57 ET342111.805
11:00 ET82511.805
11:02 ET20011.805
11:04 ET173011.78
11:06 ET163111.72
11:11 ET1276211.765
11:13 ET10011.755
11:15 ET45011.735
11:18 ET20911.68
11:22 ET10011.65
11:24 ET50011.6425
11:29 ET10011.68
11:36 ET10011.67
11:38 ET92911.62
11:51 ET35011.66
12:00 ET165811.64
12:05 ET20011.62
12:12 ET10011.625
12:14 ET271211.54
12:16 ET271411.5929
12:18 ET180011.6699
12:20 ET40311.62
12:25 ET73211.62
12:30 ET10011.66
12:32 ET50011.6555
12:34 ET10211.645
12:36 ET45011.665
12:38 ET40011.65
12:39 ET197111.67
12:41 ET140011.7
12:43 ET20011.72
12:48 ET10011.715
12:50 ET30011.74
12:52 ET32811.715
12:54 ET40011.74
12:57 ET30011.73
01:03 ET193111.76
01:06 ET20011.78
01:10 ET55511.8
01:14 ET40011.8
01:17 ET356711.75
01:19 ET10011.725
01:24 ET10011.72
01:26 ET11611.73
01:30 ET10011.71
01:32 ET10011.71
01:33 ET50311.7
01:35 ET10011.68
01:37 ET105011.66
01:44 ET66911.64
01:46 ET10211.64
01:50 ET251911.69
01:53 ET20011.72
01:55 ET10011.72
01:57 ET20011.72
02:00 ET72811.68
02:04 ET10011.71
02:06 ET10011.71
02:08 ET20011.71
02:09 ET30011.74
02:11 ET19611.7512
02:13 ET48111.75
02:15 ET40011.745
02:18 ET111211.75
02:20 ET20011.74
02:22 ET80011.74
02:24 ET120011.74
02:27 ET40011.78
02:29 ET60011.755
02:31 ET70011.74
02:33 ET10011.76
02:38 ET10011.76
02:40 ET200411.72
02:42 ET10011.72
02:45 ET10011.74
02:49 ET47111.705
02:54 ET70611.68
02:56 ET110011.6556
03:00 ET20011.7
03:02 ET56011.67
03:03 ET199911.69
03:05 ET40011.66
03:09 ET20011.66
03:12 ET45511.66
03:14 ET40011.66
03:16 ET105311.67
03:18 ET40011.68
03:21 ET60611.68
03:25 ET114211.66
03:27 ET121211.68
03:30 ET30011.69
03:32 ET20011.66
03:34 ET74611.67
03:36 ET30011.68
03:38 ET117411.66
03:39 ET10011.68
03:41 ET20011.68
03:43 ET309311.6581
03:45 ET130011.66
03:48 ET110011.67
03:50 ET339511.65
03:52 ET326011.67
03:54 ET277111.69
03:56 ET228511.64
03:57 ET265811.63
03:59 ET3487311.67
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKALV
Kalvista Pharmaceuticals Inc
492.3M
-3.7x
---
United StatesCABA
Cabaletta Bio Inc
491.9M
-5.9x
---
United StatesNGNE
Neurogene Inc
488.1M
-8.2x
---
United StatesAVTE
Aerovate Therapeutics Inc
502.7M
-5.8x
---
United StatesCMPS
Compass Pathways PLC
504.7M
-3.1x
---
United StatesNKTX
Nkarta Inc
478.5M
-2.9x
---
As of 2024-06-02

Company Information

KalVista Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting the disease hereditary angioedema (HAE). The Company is developing sebetralstat as an oral on-demand therapy for HAE attacks and has achieved target enrollment for the phase 3 KONFIDENT clinical trial. The Company is also conducting preclinical development on oral Factor XIIa (Factor XIIa) inhibitor program, which is advancing to provide the next generation of HAE therapeutics. It is also focused on development of oral plasma kallikrein inhibitors for HAE and Factor XIIa inhibitors for HAE and other indications. Plasma kallikrein is a serine protease enzyme that is a key mediator of inflammation and edema.

Contact Information

Headquarters
55 Cambridge Pkwy Ste 901ECAMBRIDGE, MA, United States 02142-1234
Phone
857-999-0075
Fax
302-531-3150

Executives

Independent Non-Executive Chairman of the Board
Brian Pereira
Chief Executive Officer, Director
Benjamin Palleiko
Chief Scientific Officer
Edward Feener
Chief Medical Officer
Paul Audhya
Chief Commercial Officer
Nicole Sweeny

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$492.3M
Revenue (TTM)
$0.00
Shares Outstanding
42.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.90
EPS
$-3.14
Book Value
$4.71
P/E Ratio
-3.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.